Next Biosciences' partners with Adcock Ingram By Next Biosciences 16 August 2023 Next Biosciences is thrilled to unveil its strategic partnership with Adcock Ingram as of July 2023, a renowned leader in the eye care field.
Dry eye decision tree – 10 years after DEWS By Jason Schmit, OD 21 February 2017 The first step in developing the most appropriate treatment plan for a patient with dry eye disease (DED) is to correctly categorise the stage and type of DED the patient exhibits using the available technology. Then address the patient’s symptoms using the appropriate evidence-based therapies.
Biological reasons for the discordance of Monosomy X By Next Biosciences 1 December 2016 While a considerable amount of data exists for clinical trials and laboratory performance for non-invasive prenatal testing (NIPT) of autosomal aneuploidies (chromosomal abnormalities), relatively little data is available on laboratory performance for sex chromosome aneuploidies.
Innovative wound-healing technique using amniotic membrane By Next Biosciences 13 July 2016 According to a recent article in Live Science, human amniotic membrane biological patches can be used to treat superficial wounds such as partial thickness burn wounds, diabetic foot ulcers, venous leg ulcers and bed sores.
Application of umbilical cord serum eyedrops for dry eye syndrome By Next Biosciences 4 November 2015 Umbilical cord serum contains essential tear components, and umbilical cord serum eyedrops are effective and safe for treating severe dry eye syndrome.
Application of umbilical cord serum eyedrops for Neurotrophic Keratitis By Next Biosciences 4 November 2015 Application of umbilical cord serum eyedrops for the treatment of Neurotrophic Keratitis
Comparison of autologous serum and umbilical cord serum eye drops By Next Biosciences 4 November 2015 To compare the therapeutic effect between autologous serum and umbilical cord serum eye drops in treating severe dry eye syndrome.
Amniotic membrane transplantation By Next Biosciences 30 October 2015 Amniotic membrane transplantation may be considered an alternative method for treating persistent epithelial defects and sterile ulceration that are refractory to conventional treatment and before considering treatment by conjunctival flaps or tarsorrhaphy.